This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Sponsored by National Taiwan University Hospital

About this trial

Last updated 3 years ago

Study ID

202212084RINC

Status

Enrolling by invitation

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18 to 70 Years
All Sexes

Trial Timing

Started 3 years ago

What is this trial about?

In Taiwan, HBV infection is endemic in the adult population. With the westernization of eating habit and lifestyle, metabolic syndrome and related non-alcoholic fatty liver diseases (NAFLD, newly proposed as metabolic dysfunction associated fatty liver diseases, MAFLD) has become another important health issue. It is therefore common to encounter subjects with concurrent MAFLD and HBV infection in HBV endemic countries. This project will study the clinical data of patients with concurrent MAFLD and HBV, and aim to explore the impact of exercise intervention on the hepatic fatty infiltration, alteration of gut microbiota and HBV replication status in this group of patients. The research strategies will include (1) improving fatty liver and metabolic syndrome in subjects with concurrent MAFLD and HBV; and (2) exploring the changes of HBV replication and intestinal microflora in patients with concurrent HBV and MAFLD after exercise intervention.

What are the participation requirements?

Inclusion Criteria

* Age >18 years of age

* Either gender

* HBV treatment naïve

* Capable of taking exercise

* HBsAg positivity for >6 months

* Evidence of fatty liver in both abdominal ultrasonography and Fibroscan™(CAP>215)

Exclusion Criteria

* Age >70 years of age

* Evidence of liver cirrhosis

* Patients fulfilling reimbursement criteria for HBV treatment

* Evidence of severe cardiopulmonary diseases

* Evidence of serious hip or knee problems, incapable of taking exercise

* Evidence of liver decompensation

* Evidence of active HCV (positive for serum HCV RNA) or HIV infection (positive for anti-HCV)

* Clinical diagnosis of Alzheimer's Disease

* Thyroid disease